BioNTech SE - ADR

NASDAQ:BNTX   3:59:52 PM EDT
333.66
-19.33 (-5.48%)
: $334.15 +0.49 (+0.15%)
Products

Pfizer And Biontech Submit FDA Application For Comirnaty Booster Dose For Patients At 16 And Older

Published: 08/25/2021 16:26 GMT
BioNTech SE - ADR (BNTX) - Pfizer and Biontech Initiate Rolling Submission of Supplemental Biologics License Application to U.S. FDA for Booster Dose of Comirnaty® in Individuals 16 and Older.companies Intend to Complete Submission of Sbla by End of This Week.